arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

MANGOCEUTICALS, INC.

MGRX

$0.19 ▼ -0.02 (-8.49%) at close

19 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

MANGOCEUTICALS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.3M

Dividend Yield —

Revenue Growth -59.1% ↘

Op. Margin None

ROIC -6.5% ↗

FCF / Share $-0.02 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

19-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$68.76K

↓ -59.1% —

Net Income Profit after all expenses

$-1.31M

↑ +75.8% —

FCF / Share Free cash flow per share

$-0.02

↑ +80.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Revenue Growth YoY (%)	-59.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-839%)	-37.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-574%)	-10.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-229%)	-36.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-560%)	3.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-62%)	-48.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-712%)	-56.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-812%)	-45.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-670%)	15.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+94%)	112.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1307%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	84.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	82.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	98.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-533.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1190.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	72.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	56.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3066.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1600.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-250.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	75.8% Excellent ↑ Excellent Improving Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.1% Weak ↑ Weak Improving Year-over-year change in net income	-281.1% Weak ↓ Weak Declining Year-over-year change in net income	-126.5% Weak ↓ Weak Declining Year-over-year change in net income	-104.4% Weak ↓ Weak Declining Year-over-year change in net income	24.1% Good ↑ Good Improving Year-over-year change in net income	-11.1% Weak ↑ Weak Improving Year-over-year change in net income	-4.7% Weak ↑ Weak Improving Year-over-year change in net income	7.5% Fair ↑ Fair Improving Year-over-year change in net income	-281.2% Weak ↑ Weak Improving Year-over-year change in net income	-9081.4% Weak ↑ Weak Improving Year-over-year change in net income	-11553.8% Weak Weak Year-over-year change in net income	-12966.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	83.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-1040.9% Weak Weak Year-over-year change in free cash flow	—	—	—	73.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	-2597.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	-1205.0% Weak Weak Year-over-year change in free cash flow	-6787.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	-21.3% Weak Weak Compound annual revenue growth over 3 years	-12.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Operating Margin (%) (%)	—	—	-389.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2698%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-378.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-462.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	30.63x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	3.97x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	195.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-261.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-52.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-95.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	187.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	88.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-785.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-244.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-62.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-67.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-25.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-18.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-48.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-28.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-288%)	-23.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-14.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-14.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-17.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	247.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1547%)	—	—	—	-67.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-547%)	-109.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-831%)	-2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	14.2% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-6%)	117.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+681%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	-278.42x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-228.69K	$-174.56K	$-1.49M	$-481.28K	$-101.02K	$-76.50K	$-58.65K	$-73.91K	$-490.24K	$-15.30K	$-739.01K	—	—	$0.00	$-682.86K	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.01	—	$0.02	—	$0.07	$0.01	$0.01	—	$0.23	$0.01	$0.01	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.09	$-0.22	$-0.01	$-0.69	$-0.57	$-1.29	$-0.52	$-0.99	$-0.09	$-0.10	$-1.90	$-1.70	$-0.14	$-0.23	$-0.06	$-0.10	$-0.04	$0.00	—
Free Cash Flow per Share (USD)	$-0.02	$-0.08	—	$-0.11	—	$-0.50	—	—	—	$-0.04	—	$-1.61	$-0.11	$-0.16	—	$-0.06	$-0.01	$-0.00	—
Book Value per Share (USD)	$0.70	$0.79	$0.96	$1.13	—	$2.83	$0.44	$6.27	$0.47	$-0.04	$0.54	—	—	$0.25	$0.05	$0.08	$-0.02	$-0.00	—
Tangible Book Value per Share (USD)	$-0.06	$-0.03	$0.06	$-0.01	—	$-0.18	$-0.04	$-0.57	$-0.03	$-0.04	$0.54	—	—	$0.25	$0.05	$0.08	$-0.02	$-0.00	—
Basic Weighted Avg Shares (shares)	17.12M	16.48M	—	11.52M	—	4.59M	—	2.01M	26.10M	22.83M	—	1.06M	15.77M	11.26M	—	10.05M	9.01M	8.00M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$-1.15M	$-525.13K	$656.87K	$-206.05K	$-1.48M	$-1.33M	$-1.35M	$-1.29M	$-860.70K	$-1.12M	$624.32K	—	—	$3.64M	$434.03K	—	—	—	—
Total Equity (USD)	$12.53M	$13.48M	$15.20M	$15.73M	$19.24M	$20.25M	$13.95M	$13.39M	$13.83M	$-958.43K	$774.75K	—	—	$3.82M	$614.03K	$823.57K	$-138.33K	$-16.72K	$-16.72K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$68.76K	$67.86K	$94.36K	$84.25K	$168.11K	$109.31K	$105.25K	$133.37K	$163.16K	$214.09K	$244.37K	$245.16K	$141.24K	$100.72K	—	—	—	—	—
Depreciation Expense (USD)	$252.00	$250.00	$255.00	$256.00	$252.00	$250.00	$255.00	—	—	$6.22K	$6.29K	$12.52K	$6.22K	$6.08K	—	—	—	—	—
Net Income, GAAP (USD)	$-1.31M	$-3.40M	$-2.77M	$-7.62M	$-5.42M	$-4.84M	$-1.95M	$-2.00M	$-2.39M	$-2.37M	$-2.57M	$-1.80M	$-2.28M	$-2.56M	$-673.65K	$-19.60K	$-19.60K	$-19.60K	—
Operating Cash Flow (USD)	$-260.51K	$-1.31M	$-1.08M	$-1.24M	—	$-2.27M	$-1.13M	—	—	$-991.13K	$-1.70M	$-1.71M	$-1.78M	$-1.81M	$-649.56K	$-600.35K	$-77.90K	$-18.71K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 19 quarters

MANGOCEUTICALS, INC.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MGRX with peers